SlideShare a Scribd company logo
Molecule wise Sales Growth
Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH
SELECTED TOTAL 8,210,086,378 100.00 1.91 23,408,089,209 100.00 2.21
1 SILDENAFIL 10,453,446 0.13 999.00 30,919,277 0.13 999.00
2 METHIONINE 8,913,934 0.11 340.33 20,618,546 0.09 437.94
3 SITAGLIPTIN 28,761,744 0.35 379.68 78,641,899 0.34 388.36
4 SULINDAC 5,183,400 0.06 383.17 15,553,388 0.07 332.12
5 ORLISTAT 9,682,042 0.12 198.97 26,316,721 0.11 175.89
6 CLAVULANIC ACID 62,278,702 0.76 189.77 155,251,098 0.66 158.23
7 VILDAGLIPTIN 40,068,840 0.49 121.11 119,663,449 0.51 133.87
8 OLMESARTAN MEDOXOMIL 38,719,606 0.47 85.00 107,793,846 0.46 77.63
9 ROSUVASTATIN 24,654,824 0.30 88.84 69,055,271 0.30 71.62
10 MEROPENEM 9,075,175 0.11 28.12 23,287,092 0.10 54.54
11 RABEPRAZOLE 88,623,926 1.08 53.96 253,110,003 1.08 51.84
12 MOXIFLOXACIN 15,088,811 0.18 42.98 43,332,482 0.19 46.64
13 BISOPROLOL 34,360,725 0.42 34.08 97,268,086 0.42 40.16
14 IRON FERRIC 19,921,867 0.24 36.25 53,299,455 0.23 35.90
15 VACCINE, TETANUS 9,067,215 0.11 27.08 18,232,066 0.08 34.66
16 KETOCONAZOLE 10,271,412 0.13 33.93 32,190,872 0.14 34.26
17 FLAVIN MONONUCLEOTIDE 13,059,880 0.16 20.62 31,087,617 0.13 33.76
18 INSULIN DETEMIR 9,034,464 0.11 -24.30 42,457,089 0.18 33.59
19 CEFPODOXIME PROXETIL 38,491,926 0.47 16.40 117,728,581 0.50 33.08
20 CHOLINE 17,787,486 0.22 27.35 42,748,293 0.18 31.70
21 METFORMIN 105,165,883 1.28 48.99 304,468,287 1.30 30.22
22 BETACAROTENE 15,286,801 0.19 44.10 38,935,847 0.17 30.02
23 GUAIFENESIN 46,840,433 0.57 114.98 123,339,248 0.53 28.97
24 ESOMEPRAZOLE 360,048,857 4.39 32.90 978,704,168 4.18 28.94
25 CHLORPHENAMINE 9,443,904 0.12 -20.57 36,928,981 0.16 24.69
26 FEXOFENADINE 45,380,090 0.55 27.15 130,055,000 0.56 24.47
27 NAPROXEN 106,127,939 1.29 28.94 288,323,401 1.23 23.36
28 PREDNISOLONE 30,129,322 0.37 13.20 87,297,708 0.37 23.16
29 INOSITOL 20,834,194 0.25 18.60 52,036,101 0.22 22.11
30 VALSARTAN 22,865,052 0.28 28.70 68,923,538 0.29 21.78
31 CLINDAMYCIN 35,970,808 0.44 18.60 111,397,943 0.48 21.62
32 DESLORATADINE 15,632,563 0.19 22.71 46,003,451 0.20 20.73
33 PREGABALIN 53,541,871 0.65 19.19 151,484,576 0.65 20.39
34 BACITRACIN 9,226,674 0.11 32.26 23,452,624 0.10 19.42
35 MONTELUKAST 128,332,003 1.56 19.05 371,262,279 1.59 18.75
36 MIDAZOLAM 9,188,624 0.11 12.92 29,955,576 0.13 18.73
37 CLONAZEPAM 89,693,413 1.09 16.08 261,920,936 1.12 18.43
38 DEXTROMETHORPHAN 38,630,508 0.47 95.29 105,200,147 0.45 18.01
39 LEVONORGESTREL 10,400,307 0.13 6.19 34,049,861 0.15 17.56
40 POVIDONE-IODINE 9,168,049 0.11 14.79 26,682,574 0.11 17.39
MARCH '13 JANUARY TO MARCH 2013
Molecule wise Sales Value Growth 1st Quarter 2013
Page 1
Molecule wise Sales Growth
Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH
MARCH '13 JANUARY TO MARCH 2013
Molecule wise Sales Value Growth 1st Quarter 2013
41 CEFUROXIME AXETIL 216,032,243 2.63 16.68 579,791,301 2.48 16.80
42 CHLORAMPHENICOL 11,779,514 0.14 11.79 33,441,318 0.14 16.32
43 LEVOSALBUTAMOL 21,613,007 0.26 14.30 62,509,158 0.27 15.78
44 NORETHISTERONE 19,359,757 0.24 18.93 53,637,429 0.23 14.36
45 DEXAMETHASONE 36,631,685 0.45 3.75 110,395,106 0.47 14.12
46 TRANEXAMIC ACID 15,584,997 0.19 -10.11 59,574,767 0.25 14.05
47 GLUCOSAMINE 33,073,829 0.40 23.02 85,319,947 0.36 13.98
48 CEFACLOR 16,502,708 0.20 1.21 51,753,243 0.22 12.83
49 TRIPROLIDINE 43,698,597 0.53 61.46 128,714,805 0.55 12.48
50 SPIRONOLACTONE 26,448,894 0.32 6.79 76,055,193 0.32 12.12
51 FUROSEMIDE 26,018,212 0.32 5.51 73,890,573 0.32 11.27
52 PSEUDOEPHEDRINE 48,378,824 0.59 56.49 142,830,508 0.61 11.22
53 DEXTROMETHORPHAN BXM 551,170 1.43 -17.24 1,623,843 1.54 10.87
54 IPRATROPIUM BROMIDE 20,150,359 0.25 8.38 61,372,299 0.26 10.54
55 ETHINYLESTRADIOL 31,320,043 0.38 3.67 88,313,625 0.38 10.30
56 ENTECAVIR 11,903,020 0.14 27.13 32,362,795 0.14 10.02
57 INSULIN ASPART PROTAMINE CRYSTALLIN42,452,001 0.52 5.00 129,823,076 0.55 9.79
58 HYDROCHLOROTHIAZIDE 89,693,844 1.09 4.04 262,938,678 1.12 8.97
59 CARBAMAZEPINE 20,766,827 0.25 -2.06 60,923,497 0.26 8.94
60 TAMSULOSIN 32,158,697 0.39 8.02 93,425,468 0.40 8.93
61 CLOBETASOL 25,381,073 0.31 23.75 65,950,002 0.28 8.92
62 TRIAMCINOLONE ACETONIDE 28,231,848 0.34 12.55 78,604,919 0.34 8.87
63 NYSTATIN 17,473,851 0.21 11.02 48,353,162 0.21 8.83
64 SODIUM 78,436,223 0.96 1.08 191,840,008 0.82 8.79
65 ESCITALOPRAM 15,071,370 0.18 -3.03 46,484,831 0.20 8.78
66 BACLOFEN 29,041,821 0.35 1.84 81,986,447 0.35 8.43
67 MICONAZOLE 16,606,908 0.20 17.78 45,715,844 0.20 8.20
68 CHONDROITINSULFURIC ACID 28,379,360 0.35 6.00 80,307,615 0.34 8.13
69 ALBENDAZOLE 12,724,372 0.15 8.04 41,650,769 0.18 7.75
70 DIOSMIN 11,351,252 0.14 6.92 35,629,542 0.15 7.67
71 HESPERIDIN 11,351,252 0.14 6.92 35,629,542 0.15 7.67
72 INSULIN HUMAN ISOPHANE 120,843,462 1.47 4.20 367,314,529 1.57 7.46
73 KETOTIFEN 46,652,666 0.57 2.26 140,645,804 0.60 7.46
74 ETORICOXIB 40,779,534 0.50 -0.09 137,080,750 0.59 7.45
75 CALCIUM 309,563,680 3.77 13.17 832,368,551 3.56 6.88
76 NEOMYCIN 40,581,677 0.49 10.15 117,739,925 0.50 6.81
77 TOLPERISONE 13,484,391 0.16 1.41 36,504,216 0.16 6.76
78 AMOXICILLIN 111,761,592 1.36 -3.08 326,373,720 1.39 6.54
79 INSULIN HUMAN BASE 138,598,702 1.69 0.18 425,411,812 1.82 6.44
80 BETAMETHASONE 36,113,500 0.44 10.70 108,652,421 0.46 6.31
81 SALMETEROL 85,341,543 1.04 -1.74 260,326,539 1.11 6.20
Page 2
Molecule wise Sales Growth
Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH
MARCH '13 JANUARY TO MARCH 2013
Molecule wise Sales Value Growth 1st Quarter 2013
82 CITRIC ACID 37,951,118 0.46 9.88 85,227,000 0.36 6.20
83 FLUTICASONE 92,809,600 1.13 -0.72 282,070,168 1.21 6.16
84 HYDROCORTISONE 18,648,897 0.23 7.29 52,386,642 0.22 6.08
85 FLUNARIZINE 17,017,584 0.21 13.13 47,026,989 0.20 5.95
86 NITROGLYCERIN 38,560,866 0.47 11.21 117,723,611 0.50 5.87
87 LETROZOLE 12,362,869 0.15 -2.96 38,730,859 0.17 5.47
88 COLECALCIFEROL 290,020,966 3.53 11.77 777,827,783 3.32 5.35
89 ATORVASTATIN 121,754,521 1.48 4.31 354,728,426 1.52 5.23
90 CEFIXIME 281,903,488 3.43 -3.69 771,499,540 3.30 5.18
91 INDOMETACIN 12,022,122 0.15 12.82 34,076,228 0.15 5.00
92 FOLIC ACID 55,391,651 0.67 13.20 148,684,677 0.64 4.94
93 VALPROIC ACID 20,992,608 0.26 -3.68 62,065,039 0.27 4.61
94 CETIRIZINE 42,773,782 0.52 -6.79 118,818,434 0.51 4.57
95 GLUCOSE 76,969,526 0.94 2.75 176,182,483 0.75 4.18
96 GLIMEPIRIDE 47,633,231 0.58 6.54 140,405,509 0.60 3.94
97 MAGALDRATE 24,452,655 0.30 39.89 64,600,695 0.28 3.66
98 ACICLOVIR 9,073,245 0.11 6.47 22,142,537 0.09 3.52
99 VITAMIN B COMPLEX 23,601,224 0.29 -3.28 64,584,521 0.28 3.46
100 COD LIVER OIL 26,216,768 0.32 6.16 62,215,239 0.27 3.35
101 CLOTRIMAZOLE 11,764,310 0.14 6.42 35,901,629 0.15 3.18
102 DESOGESTREL 11,440,797 0.14 10.12 27,201,369 0.12 2.99
103 POTASSIUM 150,571,136 1.83 5.26 388,323,961 1.66 2.94
104 NICOTINIC ACID 22,030,486 0.27 6.59 53,658,175 0.23 2.58
105 SALBUTAMOL 93,210,295 1.14 8.22 260,609,203 1.11 2.42
106 SALICYLIC ACID 12,489,394 0.15 -4.57 38,333,866 0.16 2.39
107 ZINC 124,812,849 1.52 4.90 336,117,513 1.44 2.37
108 INDAPAMIDE 14,604,524 0.18 3.94 43,153,532 0.18 2.07
109 SORBITOL 19,596,612 0.24 -7.76 36,896,848 0.16 1.98
110 MUPIROCIN 11,749,040 0.14 15.01 32,599,487 0.14 1.59
111 VITAMIN E 178,709,044 2.18 4.04 488,504,012 2.09 1.58
112 ONDANSETRON 19,262,786 0.23 0.79 57,619,774 0.25 1.38
113 AMLODIPINE 156,127,017 1.90 14.93 447,688,552 1.91 1.36
114 ACETYLSALICYLIC ACID 43,059,432 0.52 -5.07 130,556,776 0.56 0.49
115 CARVEDILOL 9,745,635 0.12 -3.28 28,862,908 0.12 0.44
116 LOSARTAN 160,306,021 1.95 3.52 471,651,227 2.01 0.27
117 RIBOFLAVIN 73,561,088 0.90 5.37 182,609,653 0.78 0.24
118 RAMIPRIL 21,231,074 0.26 -1.35 64,512,842 0.28 0.18
119 MEBEVERINE 15,808,219 0.19 -3.13 43,137,943 0.18 -0.10
120 ASCORBIC ACID 213,748,421 2.60 4.73 564,082,315 2.41 -0.17
121 BROMAZEPAM 32,867,977 0.40 -6.78 101,379,028 0.43 -0.36
122 MENTHOL 9,355,381 0.11 -14.62 30,264,969 0.13 -0.61
Page 3
Molecule wise Sales Growth
Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH
MARCH '13 JANUARY TO MARCH 2013
Molecule wise Sales Value Growth 1st Quarter 2013
123 ALLYLESTRENOL 13,039,595 0.16 -7.35 37,690,357 0.16 -0.74
124 RETINOL 127,816,797 1.56 4.71 333,850,107 1.43 -0.98
125 CEFRADINE 94,117,712 1.15 -4.24 276,218,033 1.18 -1.00
126 LACTULOSE 19,098,232 0.23 -18.01 63,136,877 0.27 -1.16
127 NICOTINAMIDE 134,611,171 1.64 4.58 346,160,742 1.48 -1.37
128 CLOPIDOGREL 67,402,068 0.82 -7.51 213,126,279 0.91 -1.63
129 METOPROLOL 10,328,363 0.13 -7.90 32,500,482 0.14 -1.83
130 BECLOMETASONE 10,219,169 0.12 4.04 27,665,204 0.12 -1.86
131 PIOGLITAZONE 35,395,741 0.43 -0.69 101,237,921 0.43 -2.35
132 SIMETICONE 64,738,200 0.79 6.15 184,342,247 0.79 -2.77
133 CARBONYL IRON 16,888,940 0.21 -1.40 48,073,868 0.21 -2.79
134 PANTOTHENIC ACID 54,558,870 0.66 5.22 144,186,572 0.62 -2.89
135 PARACETAMOL 239,246,594 2.91 -7.24 583,907,127 2.49 -3.00
136 IRON FERROUS 48,405,795 0.59 12.43 130,936,651 0.56 -3.26
137 MISOPROSTOL 22,250,800 0.27 3.44 58,283,472 0.25 -3.56
138 AZITHROMYCIN 225,447,551 2.75 -8.85 629,162,508 2.69 -3.70
139 CLARITHROMYCIN 19,051,558 0.23 -20.79 56,483,331 0.24 -3.72
140 MAGNESIUM 160,892,337 1.96 -1.48 451,116,620 1.93 -3.99
141 FLUCONAZOLE 39,338,985 0.48 0.45 115,936,587 0.50 -4.04
142 CAFFEINE 93,041,371 1.13 -12.76 238,287,249 1.02 -4.31
143 DICLOFENAC 92,194,644 1.12 -5.44 251,854,506 1.08 -4.90
144 MELITRACEN 99,040,450 1.21 -0.10 270,561,714 1.16 -5.00
145 FLUPENTIXOL 100,146,733 1.22 -0.35 274,324,065 1.17 -5.09
146 ACECLOFENAC 55,534,699 0.68 14.39 150,668,241 0.64 -5.23
147 MECOBALAMIN 10,713,208 0.13 -3.52 29,799,852 0.13 -5.38
148 LORATADINE 11,687,359 0.14 -7.59 35,947,743 0.15 -5.66
149 KETOROLAC 90,635,606 1.10 -8.75 262,838,949 1.12 -5.94
150 PROCYCLIDINE 5,173,832 0.06 8.56 13,967,482 0.06 -6.77
151 FLUCLOXACILLIN 73,832,773 0.90 13.13 211,305,035 0.90 -6.78
152 PHOSPHORUS 80,340,098 0.98 -0.33 219,110,308 0.94 -6.84
153 PROCHLORPERAZINE 9,502,693 0.12 0.14 24,232,845 0.10 -7.38
154 CEFTRIAXONE 99,951,883 1.22 -8.63 263,796,221 1.13 -8.34
155 ALUMINIUM 43,828,641 0.53 -14.51 130,644,200 0.56 -8.84
156 LEVOFLOXACIN 43,087,555 0.52 -17.12 124,642,247 0.53 -8.90
157 CIPROFLOXACIN 144,038,621 1.75 -7.94 395,474,369 1.69 -9.07
158 COPPER 36,133,681 0.44 -6.09 98,366,376 0.42 -9.27
159 TRAMADOL 23,785,071 0.29 -0.57 60,762,714 0.26 -9.50
160 ATENOLOL 99,283,879 1.21 -5.94 288,917,769 1.23 -9.62
161 THIAMINE 179,870,446 2.19 -8.61 479,060,883 2.05 -9.80
162 THREONINE 10,911,081 0.13 -6.34 19,353,848 0.08 -10.25
163 PYRIDOXINE 181,841,345 2.21 -9.83 486,771,141 2.08 -10.48
Page 4
Molecule wise Sales Growth
Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH
MARCH '13 JANUARY TO MARCH 2013
Molecule wise Sales Value Growth 1st Quarter 2013
164 KETOPROFEN 8,615,322 0.10 16.38 22,544,135 0.10 -11.20
165 METRONIDAZOLE 41,370,583 0.50 -5.06 124,409,176 0.53 -11.75
166 NITAZOXANIDE 13,336,919 0.16 -12.22 39,388,891 0.17 -11.94
167 PANTOPRAZOLE 122,973,548 1.50 2.15 314,609,120 1.34 -13.18
168 VINPOCETINE 9,158,710 0.11 8.20 25,490,232 0.11 -13.47
169 AMBROXOL 32,119,904 0.39 19.45 83,873,109 0.36 -14.21
170 HISTIDINE 37,605,796 0.46 -16.32 72,657,504 0.31 -14.46
171 MANGANESE 24,650,676 0.30 -7.25 66,909,573 0.29 -14.99
172 LYSINE 46,138,520 0.56 -14.89 90,178,260 0.39 -15.13
173 CYANOCOBALAMIN 110,875,708 1.35 -15.23 305,773,077 1.31 -15.23
174 ASPARTIC ACID 45,702,359 0.56 -15.34 89,413,811 0.38 -15.28
175 ISOLEUCINE 45,702,359 0.56 -15.34 89,413,811 0.38 -15.28
176 LEUCINE 45,702,359 0.56 -15.34 89,413,811 0.38 -15.28
177 DOXYCYCLINE 11,959,552 0.15 63.59 26,151,375 0.11 -15.43
178 BORON 22,815,706 0.28 -8.67 61,758,442 0.26 -15.74
179 GEMIFLOXACIN 15,084,672 0.18 -36.50 43,180,257 0.18 -15.84
180 VALINE 43,888,868 0.53 -15.95 86,138,012 0.37 -16.44
181 ERYTHROMYCIN 11,962,716 0.15 -17.66 36,839,711 0.16 -19.34
182 RANITIDINE 178,125,573 2.17 2.06 522,353,329 2.23 -19.93
183 DOMPERIDONE 72,892,769 0.89 -6.20 197,158,982 0.84 -22.35
184 LANSOPRAZOLE 13,287,731 0.16 -35.51 38,763,750 0.17 -22.90
185 MULTIVITAMINS AND MINERALS 21,769,520 0.27 -23.36 65,222,256 0.28 -23.69
186 FLUPHENAZINE 9,467,470 0.12 9.73 23,412,795 0.10 -23.94
187 GLUTAMIC ACID 14,775,088 0.18 -21.72 32,767,007 0.14 -25.41
188 THEOPHYLLINE 21,671,118 0.26 -14.72 59,573,430 0.25 -26.41
189 OMEPRAZOLE 360,309,899 4.39 -37.38 1,144,788,212 4.89 -28.47
190 VACCINE, RABIES 29,287,596 0.36 -54.75 86,392,042 0.37 -37.49
Md. Masum Chowdhury, Manager, SBM,Asiatic, Email-masum.pha@gmail.com
Page 5

More Related Content

What's hot

Go Ahead for F&O Report 29 January 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 29 January 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 29 January 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 29 January 2013 Mansukh Investment and Trading Solution
Mansukh Investment & Trading Solutions
 
Go Ahead for F&O Report 18 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 18 March 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 18 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 18 March 2013 Mansukh Investment and Trading Solution
Mansukh Investment & Trading Solutions
 
Future levels 01.03.13
Future levels 01.03.13Future levels 01.03.13
Go Ahead for F&O Report 13 February 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 13 February 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 13 February 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 13 February 2013 Mansukh Investment and Trading Solution
Mansukh Investment & Trading Solutions
 
Go Ahead for F&O Report 13 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 13 March 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 13 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 13 March 2013 Mansukh Investment and Trading Solution
Mansukh Investment & Trading Solutions
 
Go Ahead for F&O Report 19 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 19 March 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 19 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 19 March 2013 Mansukh Investment and Trading Solution
Mansukh Investment & Trading Solutions
 

What's hot (6)

Go Ahead for F&O Report 29 January 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 29 January 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 29 January 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 29 January 2013 Mansukh Investment and Trading Solution
 
Go Ahead for F&O Report 18 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 18 March 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 18 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 18 March 2013 Mansukh Investment and Trading Solution
 
Future levels 01.03.13
Future levels 01.03.13Future levels 01.03.13
Future levels 01.03.13
 
Go Ahead for F&O Report 13 February 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 13 February 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 13 February 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 13 February 2013 Mansukh Investment and Trading Solution
 
Go Ahead for F&O Report 13 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 13 March 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 13 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 13 March 2013 Mansukh Investment and Trading Solution
 
Go Ahead for F&O Report 19 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 19 March 2013 Mansukh Investment and Trading SolutionGo Ahead for F&O Report 19 March 2013 Mansukh Investment and Trading Solution
Go Ahead for F&O Report 19 March 2013 Mansukh Investment and Trading Solution
 

Viewers also liked

Secrets of a successful medical promotion officer
Secrets of a successful medical promotion officerSecrets of a successful medical promotion officer
Secrets of a successful medical promotion officerMohammad Masum Chowdhury
 
Advanced pharmaceutical selling skill
Advanced pharmaceutical selling skillAdvanced pharmaceutical selling skill
Advanced pharmaceutical selling skill
Mohammad Masum Chowdhury
 
Pharmaceutical marketing course
Pharmaceutical marketing coursePharmaceutical marketing course
Pharmaceutical marketing course
Madhukar Tanna
 
Basic functions of_med_rep
Basic functions of_med_repBasic functions of_med_rep
Basic functions of_med_repnitin bendre
 
Pharmaceutical business strategy and policy 2015
Pharmaceutical business strategy and policy 2015 Pharmaceutical business strategy and policy 2015
Pharmaceutical business strategy and policy 2015
Mohammad Masum Chowdhury
 
Slides for pharma selling course slideshare
Slides for pharma selling course   slideshareSlides for pharma selling course   slideshare
Slides for pharma selling course slideshareFederation University
 
Double blind field managers visit
Double blind field managers visitDouble blind field managers visit
Double blind field managers visit
Mohammad Masum Chowdhury
 
Steps to powerful pharmaceutical brands
Steps to powerful  pharmaceutical brandsSteps to powerful  pharmaceutical brands
Steps to powerful pharmaceutical brands
Mohammad Masum Chowdhury
 
Advanced Professional Selling Skills
Advanced Professional Selling SkillsAdvanced Professional Selling Skills
Advanced Professional Selling Skills
Tom Shay
 
Best use of pharmaceutical waiting time
Best use of pharmaceutical waiting timeBest use of pharmaceutical waiting time
Best use of pharmaceutical waiting time
Mohammad Masum Chowdhury
 
Optimize Medical Representatives Visits using My Sales Dialer
Optimize Medical Representatives Visits using My Sales DialerOptimize Medical Representatives Visits using My Sales Dialer
Optimize Medical Representatives Visits using My Sales Dialer
Anjul Katare
 
How to develop Rx share for continuous business growth
How to develop Rx share for continuous business growthHow to develop Rx share for continuous business growth
How to develop Rx share for continuous business growth
Mohammad Masum Chowdhury
 
Advanced Selling Skills
Advanced Selling SkillsAdvanced Selling Skills
Advanced Selling Skillsvenkateshmanoj
 
Crestor Presentation
Crestor PresentationCrestor Presentation
Crestor Presentation
hospital
 
60 PPTS-ADVANCED SELLING SKILLS-BY INDRANIL BHADURI
60 PPTS-ADVANCED SELLING SKILLS-BY INDRANIL BHADURI60 PPTS-ADVANCED SELLING SKILLS-BY INDRANIL BHADURI
60 PPTS-ADVANCED SELLING SKILLS-BY INDRANIL BHADURIIndranil Bhaduri
 
Proton pump inhibitor
Proton pump inhibitorProton pump inhibitor
Proton pump inhibitor
Asiful alam
 

Viewers also liked (20)

Secrets of a successful medical promotion officer
Secrets of a successful medical promotion officerSecrets of a successful medical promotion officer
Secrets of a successful medical promotion officer
 
Advanced pharmaceutical selling skill
Advanced pharmaceutical selling skillAdvanced pharmaceutical selling skill
Advanced pharmaceutical selling skill
 
Pharmaceutical marketing course
Pharmaceutical marketing coursePharmaceutical marketing course
Pharmaceutical marketing course
 
Basic functions of_med_rep
Basic functions of_med_repBasic functions of_med_rep
Basic functions of_med_rep
 
Pharma report 2013
Pharma report 2013Pharma report 2013
Pharma report 2013
 
Pharmaceutical business strategy and policy 2015
Pharmaceutical business strategy and policy 2015 Pharmaceutical business strategy and policy 2015
Pharmaceutical business strategy and policy 2015
 
Slides for pharma selling course slideshare
Slides for pharma selling course   slideshareSlides for pharma selling course   slideshare
Slides for pharma selling course slideshare
 
Double blind field managers visit
Double blind field managers visitDouble blind field managers visit
Double blind field managers visit
 
Steps to powerful pharmaceutical brands
Steps to powerful  pharmaceutical brandsSteps to powerful  pharmaceutical brands
Steps to powerful pharmaceutical brands
 
Advanced Professional Selling Skills
Advanced Professional Selling SkillsAdvanced Professional Selling Skills
Advanced Professional Selling Skills
 
Best use of pharmaceutical waiting time
Best use of pharmaceutical waiting timeBest use of pharmaceutical waiting time
Best use of pharmaceutical waiting time
 
Optimize Medical Representatives Visits using My Sales Dialer
Optimize Medical Representatives Visits using My Sales DialerOptimize Medical Representatives Visits using My Sales Dialer
Optimize Medical Representatives Visits using My Sales Dialer
 
Pharma detailing evolution
Pharma detailing evolutionPharma detailing evolution
Pharma detailing evolution
 
Rosuvastatin
RosuvastatinRosuvastatin
Rosuvastatin
 
How to develop Rx share for continuous business growth
How to develop Rx share for continuous business growthHow to develop Rx share for continuous business growth
How to develop Rx share for continuous business growth
 
Advanced Selling Skills
Advanced Selling SkillsAdvanced Selling Skills
Advanced Selling Skills
 
Crestor Presentation
Crestor PresentationCrestor Presentation
Crestor Presentation
 
Rosuvastatin
RosuvastatinRosuvastatin
Rosuvastatin
 
60 PPTS-ADVANCED SELLING SKILLS-BY INDRANIL BHADURI
60 PPTS-ADVANCED SELLING SKILLS-BY INDRANIL BHADURI60 PPTS-ADVANCED SELLING SKILLS-BY INDRANIL BHADURI
60 PPTS-ADVANCED SELLING SKILLS-BY INDRANIL BHADURI
 
Proton pump inhibitor
Proton pump inhibitorProton pump inhibitor
Proton pump inhibitor
 

Similar to Pharma molecule wise sales value growth 1st quarter 2013

Automated Trading Algorithm
Automated Trading AlgorithmAutomated Trading Algorithm
Automated Trading AlgorithmPiyush Chaudhry
 
Prev. repasse janeiro
Prev. repasse janeiroPrev. repasse janeiro
Prev. repasse janeiro
Walney Batista
 
24 1-2017
24 1-201724 1-2017
24 1-2017
akandarif
 
Fondo Federal Solidario Abril 2009 - Mayo 2015
Fondo Federal Solidario Abril 2009 - Mayo 2015Fondo Federal Solidario Abril 2009 - Mayo 2015
Fondo Federal Solidario Abril 2009 - Mayo 2015
Eduardo Nelson German
 
Fundeb por origem 2013
Fundeb por origem 2013Fundeb por origem 2013
Fundeb por origem 2013
conseduccubatao
 
88 Gibraltar Revised Pricelist Tower 1
88 Gibraltar Revised Pricelist Tower 188 Gibraltar Revised Pricelist Tower 1
88 Gibraltar Revised Pricelist Tower 1
88gibraltar
 
Ley de ingresos 2014 México
Ley de ingresos 2014 MéxicoLey de ingresos 2014 México
Ley de ingresos 2014 México
Alfredo Bladinieres
 
Tabla de comparacion pago de pmg 2020 completa
Tabla de comparacion pago de pmg 2020 completaTabla de comparacion pago de pmg 2020 completa
Tabla de comparacion pago de pmg 2020 completa
marcosroa2
 
Tabla de comparacion pago de pmg 2020 completa
Tabla de comparacion pago de pmg 2020 completaTabla de comparacion pago de pmg 2020 completa
Tabla de comparacion pago de pmg 2020 completa
marcosroa2
 
Ranking seguros utilidad_prima
Ranking seguros utilidad_primaRanking seguros utilidad_prima
Ranking seguros utilidad_prima
Medardo Arcaya
 
Dispach 6 meses
Dispach 6 mesesDispach 6 meses
Dispach 6 meses
Pablo Cortes
 
Escrutinio Defenitivo Elecciones 2011
Escrutinio Defenitivo Elecciones 2011Escrutinio Defenitivo Elecciones 2011
Escrutinio Defenitivo Elecciones 2011Petroleuse_
 
F&O Report 03 September 2013 Mansukh Investment and Trading Solution
F&O Report 03 September 2013 Mansukh Investment and Trading SolutionF&O Report 03 September 2013 Mansukh Investment and Trading Solution
F&O Report 03 September 2013 Mansukh Investment and Trading Solution
Mansukh Investment & Trading Solutions
 

Similar to Pharma molecule wise sales value growth 1st quarter 2013 (20)

Automated Trading Algorithm
Automated Trading AlgorithmAutomated Trading Algorithm
Automated Trading Algorithm
 
Prev. repasse janeiro
Prev. repasse janeiroPrev. repasse janeiro
Prev. repasse janeiro
 
24 1-2017
24 1-201724 1-2017
24 1-2017
 
Fondo Federal Solidario Abril 2009 - Mayo 2015
Fondo Federal Solidario Abril 2009 - Mayo 2015Fondo Federal Solidario Abril 2009 - Mayo 2015
Fondo Federal Solidario Abril 2009 - Mayo 2015
 
Fundeb por origem 2013
Fundeb por origem 2013Fundeb por origem 2013
Fundeb por origem 2013
 
Frijol para blog
Frijol para blogFrijol para blog
Frijol para blog
 
88 Gibraltar Revised Pricelist Tower 1
88 Gibraltar Revised Pricelist Tower 188 Gibraltar Revised Pricelist Tower 1
88 Gibraltar Revised Pricelist Tower 1
 
Estoque, custos e margens
Estoque, custos e margensEstoque, custos e margens
Estoque, custos e margens
 
Ley de ingresos 2014 México
Ley de ingresos 2014 MéxicoLey de ingresos 2014 México
Ley de ingresos 2014 México
 
GC-MC Report NAS DIV 2016
GC-MC Report NAS DIV 2016GC-MC Report NAS DIV 2016
GC-MC Report NAS DIV 2016
 
Tabla de comparacion pago de pmg 2020 completa
Tabla de comparacion pago de pmg 2020 completaTabla de comparacion pago de pmg 2020 completa
Tabla de comparacion pago de pmg 2020 completa
 
Tabla de comparacion pago de pmg 2020 completa
Tabla de comparacion pago de pmg 2020 completaTabla de comparacion pago de pmg 2020 completa
Tabla de comparacion pago de pmg 2020 completa
 
Delhi b tech2013
Delhi b tech2013Delhi b tech2013
Delhi b tech2013
 
Mango para blog
Mango para blogMango para blog
Mango para blog
 
Ranking seguros utilidad_prima
Ranking seguros utilidad_primaRanking seguros utilidad_prima
Ranking seguros utilidad_prima
 
GC-MC Report DALM.OT.
GC-MC Report DALM.OT.GC-MC Report DALM.OT.
GC-MC Report DALM.OT.
 
2011 Test Plot Book
2011 Test Plot Book2011 Test Plot Book
2011 Test Plot Book
 
Dispach 6 meses
Dispach 6 mesesDispach 6 meses
Dispach 6 meses
 
Escrutinio Defenitivo Elecciones 2011
Escrutinio Defenitivo Elecciones 2011Escrutinio Defenitivo Elecciones 2011
Escrutinio Defenitivo Elecciones 2011
 
F&O Report 03 September 2013 Mansukh Investment and Trading Solution
F&O Report 03 September 2013 Mansukh Investment and Trading SolutionF&O Report 03 September 2013 Mansukh Investment and Trading Solution
F&O Report 03 September 2013 Mansukh Investment and Trading Solution
 

More from Mohammad Masum Chowdhury

Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
Mohammad Masum Chowdhury
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
Mohammad Masum Chowdhury
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
Mohammad Masum Chowdhury
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
Mohammad Masum Chowdhury
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
Mohammad Masum Chowdhury
 
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
Mohammad Masum Chowdhury
 
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
Mohammad Masum Chowdhury
 
Bazarzarkaran February 2020
Bazarzarkaran February 2020Bazarzarkaran February 2020
Bazarzarkaran February 2020
Mohammad Masum Chowdhury
 
Bazarzatkaran January 2020
Bazarzatkaran January 2020Bazarzatkaran January 2020
Bazarzatkaran January 2020
Mohammad Masum Chowdhury
 
The Five Levels of Leadership by Md. Masum Chowdhury
The Five Levels of Leadership by Md. Masum Chowdhury The Five Levels of Leadership by Md. Masum Chowdhury
The Five Levels of Leadership by Md. Masum Chowdhury
Mohammad Masum Chowdhury
 
Psycho Cybernetics or Self Image Management
Psycho Cybernetics or Self Image ManagementPsycho Cybernetics or Self Image Management
Psycho Cybernetics or Self Image Management
Mohammad Masum Chowdhury
 
Professionalism practice in the workplace
Professionalism practice in the workplaceProfessionalism practice in the workplace
Professionalism practice in the workplace
Mohammad Masum Chowdhury
 
E book personal core values, belief and brand
E book personal core values, belief and brandE book personal core values, belief and brand
E book personal core values, belief and brand
Mohammad Masum Chowdhury
 
Dress slideshare .pdf
Dress  slideshare .pdfDress  slideshare .pdf
Dress slideshare .pdf
Mohammad Masum Chowdhury
 
Masum personal profile
Masum personal profileMasum personal profile
Masum personal profile
Mohammad Masum Chowdhury
 
Advanced detailing skill for pharmaceutical sales and marketing professionals
Advanced detailing skill for pharmaceutical sales and marketing professionalsAdvanced detailing skill for pharmaceutical sales and marketing professionals
Advanced detailing skill for pharmaceutical sales and marketing professionalsMohammad Masum Chowdhury
 
Pharmaceutical detailing and relationship selling skill training
Pharmaceutical detailing and relationship selling skill trainingPharmaceutical detailing and relationship selling skill training
Pharmaceutical detailing and relationship selling skill training
Mohammad Masum Chowdhury
 
Training session 1 how to create a strong & winning resume
Training session 1   how to create a strong & winning resumeTraining session 1   how to create a strong & winning resume
Training session 1 how to create a strong & winning resumeMohammad Masum Chowdhury
 
Leveraging Social Media Communication Strategy
Leveraging Social Media Communication StrategyLeveraging Social Media Communication Strategy
Leveraging Social Media Communication StrategyMohammad Masum Chowdhury
 
Bangladesh Pharma Industry Recruitment Process and People Oriented Selection
Bangladesh Pharma Industry Recruitment Process and People Oriented SelectionBangladesh Pharma Industry Recruitment Process and People Oriented Selection
Bangladesh Pharma Industry Recruitment Process and People Oriented Selection
Mohammad Masum Chowdhury
 

More from Mohammad Masum Chowdhury (20)

Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Safeguard Hand Rub Solution
Safeguard Hand Rub SolutionSafeguard Hand Rub Solution
Safeguard Hand Rub Solution
 
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
Ramadan 2020-Guidelines-How to make the most of Ramadan during COVID-29
 
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
Safe Ramadan Practices in the Context of the COVID-19 (WHO-COVID-19-Ramadan-2...
 
Bazarzarkaran February 2020
Bazarzarkaran February 2020Bazarzarkaran February 2020
Bazarzarkaran February 2020
 
Bazarzatkaran January 2020
Bazarzatkaran January 2020Bazarzatkaran January 2020
Bazarzatkaran January 2020
 
The Five Levels of Leadership by Md. Masum Chowdhury
The Five Levels of Leadership by Md. Masum Chowdhury The Five Levels of Leadership by Md. Masum Chowdhury
The Five Levels of Leadership by Md. Masum Chowdhury
 
Psycho Cybernetics or Self Image Management
Psycho Cybernetics or Self Image ManagementPsycho Cybernetics or Self Image Management
Psycho Cybernetics or Self Image Management
 
Professionalism practice in the workplace
Professionalism practice in the workplaceProfessionalism practice in the workplace
Professionalism practice in the workplace
 
E book personal core values, belief and brand
E book personal core values, belief and brandE book personal core values, belief and brand
E book personal core values, belief and brand
 
Dress slideshare .pdf
Dress  slideshare .pdfDress  slideshare .pdf
Dress slideshare .pdf
 
Masum personal profile
Masum personal profileMasum personal profile
Masum personal profile
 
Advanced detailing skill for pharmaceutical sales and marketing professionals
Advanced detailing skill for pharmaceutical sales and marketing professionalsAdvanced detailing skill for pharmaceutical sales and marketing professionals
Advanced detailing skill for pharmaceutical sales and marketing professionals
 
Pharmaceutical detailing and relationship selling skill training
Pharmaceutical detailing and relationship selling skill trainingPharmaceutical detailing and relationship selling skill training
Pharmaceutical detailing and relationship selling skill training
 
Training session 1 how to create a strong & winning resume
Training session 1   how to create a strong & winning resumeTraining session 1   how to create a strong & winning resume
Training session 1 how to create a strong & winning resume
 
Leveraging Social Media Communication Strategy
Leveraging Social Media Communication StrategyLeveraging Social Media Communication Strategy
Leveraging Social Media Communication Strategy
 
Bangladesh Pharma Industry Recruitment Process and People Oriented Selection
Bangladesh Pharma Industry Recruitment Process and People Oriented SelectionBangladesh Pharma Industry Recruitment Process and People Oriented Selection
Bangladesh Pharma Industry Recruitment Process and People Oriented Selection
 

Recently uploaded

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 

Recently uploaded (20)

Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 

Pharma molecule wise sales value growth 1st quarter 2013

  • 1. Molecule wise Sales Growth Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH SELECTED TOTAL 8,210,086,378 100.00 1.91 23,408,089,209 100.00 2.21 1 SILDENAFIL 10,453,446 0.13 999.00 30,919,277 0.13 999.00 2 METHIONINE 8,913,934 0.11 340.33 20,618,546 0.09 437.94 3 SITAGLIPTIN 28,761,744 0.35 379.68 78,641,899 0.34 388.36 4 SULINDAC 5,183,400 0.06 383.17 15,553,388 0.07 332.12 5 ORLISTAT 9,682,042 0.12 198.97 26,316,721 0.11 175.89 6 CLAVULANIC ACID 62,278,702 0.76 189.77 155,251,098 0.66 158.23 7 VILDAGLIPTIN 40,068,840 0.49 121.11 119,663,449 0.51 133.87 8 OLMESARTAN MEDOXOMIL 38,719,606 0.47 85.00 107,793,846 0.46 77.63 9 ROSUVASTATIN 24,654,824 0.30 88.84 69,055,271 0.30 71.62 10 MEROPENEM 9,075,175 0.11 28.12 23,287,092 0.10 54.54 11 RABEPRAZOLE 88,623,926 1.08 53.96 253,110,003 1.08 51.84 12 MOXIFLOXACIN 15,088,811 0.18 42.98 43,332,482 0.19 46.64 13 BISOPROLOL 34,360,725 0.42 34.08 97,268,086 0.42 40.16 14 IRON FERRIC 19,921,867 0.24 36.25 53,299,455 0.23 35.90 15 VACCINE, TETANUS 9,067,215 0.11 27.08 18,232,066 0.08 34.66 16 KETOCONAZOLE 10,271,412 0.13 33.93 32,190,872 0.14 34.26 17 FLAVIN MONONUCLEOTIDE 13,059,880 0.16 20.62 31,087,617 0.13 33.76 18 INSULIN DETEMIR 9,034,464 0.11 -24.30 42,457,089 0.18 33.59 19 CEFPODOXIME PROXETIL 38,491,926 0.47 16.40 117,728,581 0.50 33.08 20 CHOLINE 17,787,486 0.22 27.35 42,748,293 0.18 31.70 21 METFORMIN 105,165,883 1.28 48.99 304,468,287 1.30 30.22 22 BETACAROTENE 15,286,801 0.19 44.10 38,935,847 0.17 30.02 23 GUAIFENESIN 46,840,433 0.57 114.98 123,339,248 0.53 28.97 24 ESOMEPRAZOLE 360,048,857 4.39 32.90 978,704,168 4.18 28.94 25 CHLORPHENAMINE 9,443,904 0.12 -20.57 36,928,981 0.16 24.69 26 FEXOFENADINE 45,380,090 0.55 27.15 130,055,000 0.56 24.47 27 NAPROXEN 106,127,939 1.29 28.94 288,323,401 1.23 23.36 28 PREDNISOLONE 30,129,322 0.37 13.20 87,297,708 0.37 23.16 29 INOSITOL 20,834,194 0.25 18.60 52,036,101 0.22 22.11 30 VALSARTAN 22,865,052 0.28 28.70 68,923,538 0.29 21.78 31 CLINDAMYCIN 35,970,808 0.44 18.60 111,397,943 0.48 21.62 32 DESLORATADINE 15,632,563 0.19 22.71 46,003,451 0.20 20.73 33 PREGABALIN 53,541,871 0.65 19.19 151,484,576 0.65 20.39 34 BACITRACIN 9,226,674 0.11 32.26 23,452,624 0.10 19.42 35 MONTELUKAST 128,332,003 1.56 19.05 371,262,279 1.59 18.75 36 MIDAZOLAM 9,188,624 0.11 12.92 29,955,576 0.13 18.73 37 CLONAZEPAM 89,693,413 1.09 16.08 261,920,936 1.12 18.43 38 DEXTROMETHORPHAN 38,630,508 0.47 95.29 105,200,147 0.45 18.01 39 LEVONORGESTREL 10,400,307 0.13 6.19 34,049,861 0.15 17.56 40 POVIDONE-IODINE 9,168,049 0.11 14.79 26,682,574 0.11 17.39 MARCH '13 JANUARY TO MARCH 2013 Molecule wise Sales Value Growth 1st Quarter 2013 Page 1
  • 2. Molecule wise Sales Growth Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH MARCH '13 JANUARY TO MARCH 2013 Molecule wise Sales Value Growth 1st Quarter 2013 41 CEFUROXIME AXETIL 216,032,243 2.63 16.68 579,791,301 2.48 16.80 42 CHLORAMPHENICOL 11,779,514 0.14 11.79 33,441,318 0.14 16.32 43 LEVOSALBUTAMOL 21,613,007 0.26 14.30 62,509,158 0.27 15.78 44 NORETHISTERONE 19,359,757 0.24 18.93 53,637,429 0.23 14.36 45 DEXAMETHASONE 36,631,685 0.45 3.75 110,395,106 0.47 14.12 46 TRANEXAMIC ACID 15,584,997 0.19 -10.11 59,574,767 0.25 14.05 47 GLUCOSAMINE 33,073,829 0.40 23.02 85,319,947 0.36 13.98 48 CEFACLOR 16,502,708 0.20 1.21 51,753,243 0.22 12.83 49 TRIPROLIDINE 43,698,597 0.53 61.46 128,714,805 0.55 12.48 50 SPIRONOLACTONE 26,448,894 0.32 6.79 76,055,193 0.32 12.12 51 FUROSEMIDE 26,018,212 0.32 5.51 73,890,573 0.32 11.27 52 PSEUDOEPHEDRINE 48,378,824 0.59 56.49 142,830,508 0.61 11.22 53 DEXTROMETHORPHAN BXM 551,170 1.43 -17.24 1,623,843 1.54 10.87 54 IPRATROPIUM BROMIDE 20,150,359 0.25 8.38 61,372,299 0.26 10.54 55 ETHINYLESTRADIOL 31,320,043 0.38 3.67 88,313,625 0.38 10.30 56 ENTECAVIR 11,903,020 0.14 27.13 32,362,795 0.14 10.02 57 INSULIN ASPART PROTAMINE CRYSTALLIN42,452,001 0.52 5.00 129,823,076 0.55 9.79 58 HYDROCHLOROTHIAZIDE 89,693,844 1.09 4.04 262,938,678 1.12 8.97 59 CARBAMAZEPINE 20,766,827 0.25 -2.06 60,923,497 0.26 8.94 60 TAMSULOSIN 32,158,697 0.39 8.02 93,425,468 0.40 8.93 61 CLOBETASOL 25,381,073 0.31 23.75 65,950,002 0.28 8.92 62 TRIAMCINOLONE ACETONIDE 28,231,848 0.34 12.55 78,604,919 0.34 8.87 63 NYSTATIN 17,473,851 0.21 11.02 48,353,162 0.21 8.83 64 SODIUM 78,436,223 0.96 1.08 191,840,008 0.82 8.79 65 ESCITALOPRAM 15,071,370 0.18 -3.03 46,484,831 0.20 8.78 66 BACLOFEN 29,041,821 0.35 1.84 81,986,447 0.35 8.43 67 MICONAZOLE 16,606,908 0.20 17.78 45,715,844 0.20 8.20 68 CHONDROITINSULFURIC ACID 28,379,360 0.35 6.00 80,307,615 0.34 8.13 69 ALBENDAZOLE 12,724,372 0.15 8.04 41,650,769 0.18 7.75 70 DIOSMIN 11,351,252 0.14 6.92 35,629,542 0.15 7.67 71 HESPERIDIN 11,351,252 0.14 6.92 35,629,542 0.15 7.67 72 INSULIN HUMAN ISOPHANE 120,843,462 1.47 4.20 367,314,529 1.57 7.46 73 KETOTIFEN 46,652,666 0.57 2.26 140,645,804 0.60 7.46 74 ETORICOXIB 40,779,534 0.50 -0.09 137,080,750 0.59 7.45 75 CALCIUM 309,563,680 3.77 13.17 832,368,551 3.56 6.88 76 NEOMYCIN 40,581,677 0.49 10.15 117,739,925 0.50 6.81 77 TOLPERISONE 13,484,391 0.16 1.41 36,504,216 0.16 6.76 78 AMOXICILLIN 111,761,592 1.36 -3.08 326,373,720 1.39 6.54 79 INSULIN HUMAN BASE 138,598,702 1.69 0.18 425,411,812 1.82 6.44 80 BETAMETHASONE 36,113,500 0.44 10.70 108,652,421 0.46 6.31 81 SALMETEROL 85,341,543 1.04 -1.74 260,326,539 1.11 6.20 Page 2
  • 3. Molecule wise Sales Growth Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH MARCH '13 JANUARY TO MARCH 2013 Molecule wise Sales Value Growth 1st Quarter 2013 82 CITRIC ACID 37,951,118 0.46 9.88 85,227,000 0.36 6.20 83 FLUTICASONE 92,809,600 1.13 -0.72 282,070,168 1.21 6.16 84 HYDROCORTISONE 18,648,897 0.23 7.29 52,386,642 0.22 6.08 85 FLUNARIZINE 17,017,584 0.21 13.13 47,026,989 0.20 5.95 86 NITROGLYCERIN 38,560,866 0.47 11.21 117,723,611 0.50 5.87 87 LETROZOLE 12,362,869 0.15 -2.96 38,730,859 0.17 5.47 88 COLECALCIFEROL 290,020,966 3.53 11.77 777,827,783 3.32 5.35 89 ATORVASTATIN 121,754,521 1.48 4.31 354,728,426 1.52 5.23 90 CEFIXIME 281,903,488 3.43 -3.69 771,499,540 3.30 5.18 91 INDOMETACIN 12,022,122 0.15 12.82 34,076,228 0.15 5.00 92 FOLIC ACID 55,391,651 0.67 13.20 148,684,677 0.64 4.94 93 VALPROIC ACID 20,992,608 0.26 -3.68 62,065,039 0.27 4.61 94 CETIRIZINE 42,773,782 0.52 -6.79 118,818,434 0.51 4.57 95 GLUCOSE 76,969,526 0.94 2.75 176,182,483 0.75 4.18 96 GLIMEPIRIDE 47,633,231 0.58 6.54 140,405,509 0.60 3.94 97 MAGALDRATE 24,452,655 0.30 39.89 64,600,695 0.28 3.66 98 ACICLOVIR 9,073,245 0.11 6.47 22,142,537 0.09 3.52 99 VITAMIN B COMPLEX 23,601,224 0.29 -3.28 64,584,521 0.28 3.46 100 COD LIVER OIL 26,216,768 0.32 6.16 62,215,239 0.27 3.35 101 CLOTRIMAZOLE 11,764,310 0.14 6.42 35,901,629 0.15 3.18 102 DESOGESTREL 11,440,797 0.14 10.12 27,201,369 0.12 2.99 103 POTASSIUM 150,571,136 1.83 5.26 388,323,961 1.66 2.94 104 NICOTINIC ACID 22,030,486 0.27 6.59 53,658,175 0.23 2.58 105 SALBUTAMOL 93,210,295 1.14 8.22 260,609,203 1.11 2.42 106 SALICYLIC ACID 12,489,394 0.15 -4.57 38,333,866 0.16 2.39 107 ZINC 124,812,849 1.52 4.90 336,117,513 1.44 2.37 108 INDAPAMIDE 14,604,524 0.18 3.94 43,153,532 0.18 2.07 109 SORBITOL 19,596,612 0.24 -7.76 36,896,848 0.16 1.98 110 MUPIROCIN 11,749,040 0.14 15.01 32,599,487 0.14 1.59 111 VITAMIN E 178,709,044 2.18 4.04 488,504,012 2.09 1.58 112 ONDANSETRON 19,262,786 0.23 0.79 57,619,774 0.25 1.38 113 AMLODIPINE 156,127,017 1.90 14.93 447,688,552 1.91 1.36 114 ACETYLSALICYLIC ACID 43,059,432 0.52 -5.07 130,556,776 0.56 0.49 115 CARVEDILOL 9,745,635 0.12 -3.28 28,862,908 0.12 0.44 116 LOSARTAN 160,306,021 1.95 3.52 471,651,227 2.01 0.27 117 RIBOFLAVIN 73,561,088 0.90 5.37 182,609,653 0.78 0.24 118 RAMIPRIL 21,231,074 0.26 -1.35 64,512,842 0.28 0.18 119 MEBEVERINE 15,808,219 0.19 -3.13 43,137,943 0.18 -0.10 120 ASCORBIC ACID 213,748,421 2.60 4.73 564,082,315 2.41 -0.17 121 BROMAZEPAM 32,867,977 0.40 -6.78 101,379,028 0.43 -0.36 122 MENTHOL 9,355,381 0.11 -14.62 30,264,969 0.13 -0.61 Page 3
  • 4. Molecule wise Sales Growth Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH MARCH '13 JANUARY TO MARCH 2013 Molecule wise Sales Value Growth 1st Quarter 2013 123 ALLYLESTRENOL 13,039,595 0.16 -7.35 37,690,357 0.16 -0.74 124 RETINOL 127,816,797 1.56 4.71 333,850,107 1.43 -0.98 125 CEFRADINE 94,117,712 1.15 -4.24 276,218,033 1.18 -1.00 126 LACTULOSE 19,098,232 0.23 -18.01 63,136,877 0.27 -1.16 127 NICOTINAMIDE 134,611,171 1.64 4.58 346,160,742 1.48 -1.37 128 CLOPIDOGREL 67,402,068 0.82 -7.51 213,126,279 0.91 -1.63 129 METOPROLOL 10,328,363 0.13 -7.90 32,500,482 0.14 -1.83 130 BECLOMETASONE 10,219,169 0.12 4.04 27,665,204 0.12 -1.86 131 PIOGLITAZONE 35,395,741 0.43 -0.69 101,237,921 0.43 -2.35 132 SIMETICONE 64,738,200 0.79 6.15 184,342,247 0.79 -2.77 133 CARBONYL IRON 16,888,940 0.21 -1.40 48,073,868 0.21 -2.79 134 PANTOTHENIC ACID 54,558,870 0.66 5.22 144,186,572 0.62 -2.89 135 PARACETAMOL 239,246,594 2.91 -7.24 583,907,127 2.49 -3.00 136 IRON FERROUS 48,405,795 0.59 12.43 130,936,651 0.56 -3.26 137 MISOPROSTOL 22,250,800 0.27 3.44 58,283,472 0.25 -3.56 138 AZITHROMYCIN 225,447,551 2.75 -8.85 629,162,508 2.69 -3.70 139 CLARITHROMYCIN 19,051,558 0.23 -20.79 56,483,331 0.24 -3.72 140 MAGNESIUM 160,892,337 1.96 -1.48 451,116,620 1.93 -3.99 141 FLUCONAZOLE 39,338,985 0.48 0.45 115,936,587 0.50 -4.04 142 CAFFEINE 93,041,371 1.13 -12.76 238,287,249 1.02 -4.31 143 DICLOFENAC 92,194,644 1.12 -5.44 251,854,506 1.08 -4.90 144 MELITRACEN 99,040,450 1.21 -0.10 270,561,714 1.16 -5.00 145 FLUPENTIXOL 100,146,733 1.22 -0.35 274,324,065 1.17 -5.09 146 ACECLOFENAC 55,534,699 0.68 14.39 150,668,241 0.64 -5.23 147 MECOBALAMIN 10,713,208 0.13 -3.52 29,799,852 0.13 -5.38 148 LORATADINE 11,687,359 0.14 -7.59 35,947,743 0.15 -5.66 149 KETOROLAC 90,635,606 1.10 -8.75 262,838,949 1.12 -5.94 150 PROCYCLIDINE 5,173,832 0.06 8.56 13,967,482 0.06 -6.77 151 FLUCLOXACILLIN 73,832,773 0.90 13.13 211,305,035 0.90 -6.78 152 PHOSPHORUS 80,340,098 0.98 -0.33 219,110,308 0.94 -6.84 153 PROCHLORPERAZINE 9,502,693 0.12 0.14 24,232,845 0.10 -7.38 154 CEFTRIAXONE 99,951,883 1.22 -8.63 263,796,221 1.13 -8.34 155 ALUMINIUM 43,828,641 0.53 -14.51 130,644,200 0.56 -8.84 156 LEVOFLOXACIN 43,087,555 0.52 -17.12 124,642,247 0.53 -8.90 157 CIPROFLOXACIN 144,038,621 1.75 -7.94 395,474,369 1.69 -9.07 158 COPPER 36,133,681 0.44 -6.09 98,366,376 0.42 -9.27 159 TRAMADOL 23,785,071 0.29 -0.57 60,762,714 0.26 -9.50 160 ATENOLOL 99,283,879 1.21 -5.94 288,917,769 1.23 -9.62 161 THIAMINE 179,870,446 2.19 -8.61 479,060,883 2.05 -9.80 162 THREONINE 10,911,081 0.13 -6.34 19,353,848 0.08 -10.25 163 PYRIDOXINE 181,841,345 2.21 -9.83 486,771,141 2.08 -10.48 Page 4
  • 5. Molecule wise Sales Growth Sl. PRODUCT DESC VALUE SHARE GROWTH VALUE SHARE GROWTH MARCH '13 JANUARY TO MARCH 2013 Molecule wise Sales Value Growth 1st Quarter 2013 164 KETOPROFEN 8,615,322 0.10 16.38 22,544,135 0.10 -11.20 165 METRONIDAZOLE 41,370,583 0.50 -5.06 124,409,176 0.53 -11.75 166 NITAZOXANIDE 13,336,919 0.16 -12.22 39,388,891 0.17 -11.94 167 PANTOPRAZOLE 122,973,548 1.50 2.15 314,609,120 1.34 -13.18 168 VINPOCETINE 9,158,710 0.11 8.20 25,490,232 0.11 -13.47 169 AMBROXOL 32,119,904 0.39 19.45 83,873,109 0.36 -14.21 170 HISTIDINE 37,605,796 0.46 -16.32 72,657,504 0.31 -14.46 171 MANGANESE 24,650,676 0.30 -7.25 66,909,573 0.29 -14.99 172 LYSINE 46,138,520 0.56 -14.89 90,178,260 0.39 -15.13 173 CYANOCOBALAMIN 110,875,708 1.35 -15.23 305,773,077 1.31 -15.23 174 ASPARTIC ACID 45,702,359 0.56 -15.34 89,413,811 0.38 -15.28 175 ISOLEUCINE 45,702,359 0.56 -15.34 89,413,811 0.38 -15.28 176 LEUCINE 45,702,359 0.56 -15.34 89,413,811 0.38 -15.28 177 DOXYCYCLINE 11,959,552 0.15 63.59 26,151,375 0.11 -15.43 178 BORON 22,815,706 0.28 -8.67 61,758,442 0.26 -15.74 179 GEMIFLOXACIN 15,084,672 0.18 -36.50 43,180,257 0.18 -15.84 180 VALINE 43,888,868 0.53 -15.95 86,138,012 0.37 -16.44 181 ERYTHROMYCIN 11,962,716 0.15 -17.66 36,839,711 0.16 -19.34 182 RANITIDINE 178,125,573 2.17 2.06 522,353,329 2.23 -19.93 183 DOMPERIDONE 72,892,769 0.89 -6.20 197,158,982 0.84 -22.35 184 LANSOPRAZOLE 13,287,731 0.16 -35.51 38,763,750 0.17 -22.90 185 MULTIVITAMINS AND MINERALS 21,769,520 0.27 -23.36 65,222,256 0.28 -23.69 186 FLUPHENAZINE 9,467,470 0.12 9.73 23,412,795 0.10 -23.94 187 GLUTAMIC ACID 14,775,088 0.18 -21.72 32,767,007 0.14 -25.41 188 THEOPHYLLINE 21,671,118 0.26 -14.72 59,573,430 0.25 -26.41 189 OMEPRAZOLE 360,309,899 4.39 -37.38 1,144,788,212 4.89 -28.47 190 VACCINE, RABIES 29,287,596 0.36 -54.75 86,392,042 0.37 -37.49 Md. Masum Chowdhury, Manager, SBM,Asiatic, Email-masum.pha@gmail.com Page 5